A patient sits in my office describing "anger problems." He reports explosive outbursts, tension with his partner, and feeling "out of control." His previous therapist taught him cognitive techniques: ...

Major depressive disorder (MDD) affects about 10.4 percent of adults in one year and 20.6 percent over a lifetime (Hasin, 2018). Unfortunately, by themselves, psychotherapy and antidepressants only ...

With four FDA-approved oncology indications and trials exploring new uses, tumor treating fields are emerging as a promising therapeutic option for certain patients with cancer. While using ...

Between themed TV specials, novelty candy flavors and the pageantry of the mass-produced costume, Halloween has become so thoroughly Americanized that we often forget the holiday grew from much more ...

Imagine Halloween never had the looming dread of school or work the next day. With Oct. 31 falling on a Friday this year, that's not a problem. But since Halloween often falls on a weekday, the ...

As understanding of neurogenic rosacea’s pathophysiology evolves, signs point to its being both a manifestation of overall rosacea pathology and a distinct subtype warranting its own treatment ...

Electricity is gaining newfound traction as a potential treatment for diseases, from rheumatoid arthritis to hard-to-treat cancers including glioblastoma and pancreatic cancer. Pacemakers for decades ...

It’s so hard to get through the day without a little treat. It feels right to pick up an iced matcha in the morning or a cold brew in the afternoon, and just as nice to grab takeout in the evening as ...

Scientists from Belgian biotech company etherna, who are working on inverse RNA vaccines for multiple sclerosis and other autoimmune diseases. For decades, the only option available to patients ...

Warts are stubborn, contagious, and often misunderstood. Luke Johnson, MD, a dermatologist with University of Utah Health, shares what actually helps—from over-the-counter salicylic acid to in-office ...

The traditional understanding of inflammation attributes the process primarily to immune cells responding to tissue damage or pathogen invasion. However, a growing body of research has revealed a ...

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR ...